Population-based evaluation of future burden of disease and costs related to chronic hepatitis C and antiviral treatment strategies

被引：0
|
作者：
Siebert, U
Sroczynski, G
Aidelsburger, P
Conrads-Frank, A
Esteban, E
Wasem, J
Rossol, S
Ravens-Sieberer, U
Wong, JB
机构：
[1] Harvard Univ, Sch Med, Boston, MA USA
[2] Univ Duisburg Gesamthsch, D-4100 Duisburg, Germany
[3] Univ Munich, Inst Med Informat Biostat & Epidemiol, Munich, Germany
[4] Univ Mainz, Russelsheim, Germany
[5] Robert Koch Inst, D-1000 Berlin, Germany
[6] Tufts Univ, Sch Med, Boston, MA 02111 USA
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)65641-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：639 / 639
页数：1
相关论文
共 50 条
  • [31] Impact of improved treatment on disease burden of chronic hepatitis C in New Zealand
    Gane, Edward
    Stedman, Catherine
    Brunton, Cheryl
    Radke, Sarah
    Henderson, Charles
    Estes, Chris
    Razavi, Homie
    NEW ZEALAND MEDICAL JOURNAL, 2014, 127 (1407) : 61 - 74
  • [32] POTENTIAL IMPACT OF IMPROVED TREATMENT ON DISEASE BURDEN OF CHRONIC HEPATITIS C IN AUSTRALIA
    Dore, G. J.
    Razavi, H.
    Estes, C.
    Thompson, A.
    Zekry, A.
    Roberts, S.
    Sievert, W.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S210 - S210
  • [33] Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease Burden
    Hajarizadeh, Behzad
    Razavi-Shearer, Devin
    Merat, Shahin
    Alavian, Seyed Moayed
    Malekzadeh, Reza
    Razavi, Homie
    HEPATITIS MONTHLY, 2016, 16 (07)
  • [34] The estimated future disease burden of hepatitis C virus in the Netherlands with different treatment paradigms
    Willemse, S. B.
    Razavi-Shearer, D.
    Zuure, F. R.
    Veldhuijzen, I. K.
    Croes, E. A.
    van der Meer, A. J.
    van Santen, D. K.
    de Vree, J. M.
    de Knegt, R. J.
    Zaaijer, H. L.
    Reesink, H. W.
    Prins, M.
    Razavi, H.
    NETHERLANDS JOURNAL OF MEDICINE, 2015, 73 (09):
  • [35] CLINICAL BURDEN OF CHRONIC HEPATITIS B CARRIAGE IN GREENLAND. A POPULATION-BASED LONGITUDINAL STUDY
    Borresen, M. L.
    Ladefoged, K.
    Melbye, M.
    Kleist, I.
    Koch, A.
    INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH, 2013, 72 : 752 - 752
  • [36] Exposure to Endocrine Disrupting Chemicals in Canada: Population-Based Estimates of Disease Burden and Economic Costs
    Malits, Julia
    Naidu, Mrudula
    Trasande, Leonardo
    TOXICS, 2022, 10 (03)
  • [37] Modeling the fiscal costs and benefits of alternative treatment strategies in the United Kingdom for chronic hepatitis C
    Connolly, Mark P.
    Kotsopoulos, Nikos
    Ustianowski, Andrew
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (01) : 19 - 26
  • [38] Antiviral therapy in patients with chronic hepatitis C related hepatocellular carcinoma responding to palliative treatment
    Lee, J. I.
    Lee, K. S.
    Kim, J. K.
    Yoo, J. H.
    Chang, H. Y.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S531 - S531
  • [39] Costs of a Guideline-Based Treatment of Patients with Chronic Hepatitis C in Germany
    Stahmeyer, J. T.
    Rossol, S.
    Bert, F.
    Abdelfattah, M.
    Krauth, C.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2014, 52 (09): : 1041 - 1049
  • [40] EVALUATION OF ANTIVIRAL THERAPY TREATMENT FOR LIVER CIRRHOSIS CAUSED BY CHRONIC HEPATITIS C AND HEPATITIS C BY 31P-MRS, BASED ON METABOLITE DETECTION
    Gu, J. S.
    Sun, R. R.
    Shen, S.
    Yu, Z. J.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2015, 29 (02): : 443 - 450
12345